Page 212 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 212
Viral Hepatitis: Hepatitis B & D - Experimental (Cont.)
P0536 OSTEOPONTIN IS INVOLVED IN CHRONIC HBV INFECTION
AND ENHANCES HBV REPLICATION AND HBSAG SECRETION
Sandra Phillips*, Jason Coombes, Sameer Mistry, Roger Williams,
Wing Syn, Shilpa Chokshi, The United Kingdom
P0537 DATING THE ORIGIN OF HBV USING FULL-LENGTH
SEQUENCES
Dimitrios Paraskevis*, Kostantinos Angelis, Gkikas Magiorkinis,
Evangelia Kostaki, Simon Ho, Angelos Hatzakis, Greece
P0538 TRACING HBV GENETIC HISTORY IN THE ARCTIC:
EVIDENCE FOR A CENTRAL ASIAN HBV ORIGIN IN
GREENLAND
Dimitrios Paraskevis*, Kostantinos Angelis, Gkikas Magiorkinis,
Carla Osiowy, Malene Børresen, Anders Koch, Simon Y. Ho, Frank Jia,
Jean-Pierre Allain, Angelos Hatzakis, Greece
P0539 EXPRESSION PROFILE OF TIM-3 INDUCED BY MULTIPLE
CYTOKINES AND ANTIGENS IN PATIENTS WITH CHRONIC
ePOSTERS HEPATITIS B
Jie Dong*, China
P0540 THE SUBSTITUTION AT RT269 IN HEPATITIS B VIRUS
POLYMERASE IS ASSOCIATED WITH THE MULTI-DRUG
RESISTANCE AS A COMPENSATORY MUTATION
Sung Hyun Ahn,Yong Kwang Park, Eun-Sook Park, Doo Hyun Kim,
Beom Kyung Kim, Ah Ram Lee, Sang Hoon Ahn, Kyun-Hwan Kim*,
South Korea
P0541 SMALL INTESTINAL PERMEABILITY IS ELEVATED IN
CHRONIC VIRAL HEPATITIS PRIOR TO THE DEVELOPMENT
OF CIRRHOSIS, AND IS ASSOCIATED WITH THE DEGREE
OF FIBROSIS
Ashok S. Raj*, Gerald Holtmann, Linda Fletcher, Purnima Bhat,
Cuong Tran, Marrianne Black, Karthik Nath, Welson Jao, David Vesey,
Graeme A. Macdonald, Australia
P0542 THERAPEUTIC EFFECT AGAINST HEPATITIS B OF
VARIOUS NUCLEIC ACID POLYMERS IN THE CHRONIC
DHBV INFECTION MODEL
Celia Brikh, Catherine Jamard, Jonathan Quinet, Chaneze Bouchareb,
Ingo Roehl, Andrew Vaillant, Lucyna Cova*, France
212 The International Liver Congress™ 2015 • ILC Programme
P0536 OSTEOPONTIN IS INVOLVED IN CHRONIC HBV INFECTION
AND ENHANCES HBV REPLICATION AND HBSAG SECRETION
Sandra Phillips*, Jason Coombes, Sameer Mistry, Roger Williams,
Wing Syn, Shilpa Chokshi, The United Kingdom
P0537 DATING THE ORIGIN OF HBV USING FULL-LENGTH
SEQUENCES
Dimitrios Paraskevis*, Kostantinos Angelis, Gkikas Magiorkinis,
Evangelia Kostaki, Simon Ho, Angelos Hatzakis, Greece
P0538 TRACING HBV GENETIC HISTORY IN THE ARCTIC:
EVIDENCE FOR A CENTRAL ASIAN HBV ORIGIN IN
GREENLAND
Dimitrios Paraskevis*, Kostantinos Angelis, Gkikas Magiorkinis,
Carla Osiowy, Malene Børresen, Anders Koch, Simon Y. Ho, Frank Jia,
Jean-Pierre Allain, Angelos Hatzakis, Greece
P0539 EXPRESSION PROFILE OF TIM-3 INDUCED BY MULTIPLE
CYTOKINES AND ANTIGENS IN PATIENTS WITH CHRONIC
ePOSTERS HEPATITIS B
Jie Dong*, China
P0540 THE SUBSTITUTION AT RT269 IN HEPATITIS B VIRUS
POLYMERASE IS ASSOCIATED WITH THE MULTI-DRUG
RESISTANCE AS A COMPENSATORY MUTATION
Sung Hyun Ahn,Yong Kwang Park, Eun-Sook Park, Doo Hyun Kim,
Beom Kyung Kim, Ah Ram Lee, Sang Hoon Ahn, Kyun-Hwan Kim*,
South Korea
P0541 SMALL INTESTINAL PERMEABILITY IS ELEVATED IN
CHRONIC VIRAL HEPATITIS PRIOR TO THE DEVELOPMENT
OF CIRRHOSIS, AND IS ASSOCIATED WITH THE DEGREE
OF FIBROSIS
Ashok S. Raj*, Gerald Holtmann, Linda Fletcher, Purnima Bhat,
Cuong Tran, Marrianne Black, Karthik Nath, Welson Jao, David Vesey,
Graeme A. Macdonald, Australia
P0542 THERAPEUTIC EFFECT AGAINST HEPATITIS B OF
VARIOUS NUCLEIC ACID POLYMERS IN THE CHRONIC
DHBV INFECTION MODEL
Celia Brikh, Catherine Jamard, Jonathan Quinet, Chaneze Bouchareb,
Ingo Roehl, Andrew Vaillant, Lucyna Cova*, France
212 The International Liver Congress™ 2015 • ILC Programme
